Identification of common key genes and pathways between type 1 diabetes and multiple sclerosis using transcriptome...

Area of Science:

• Immunology and Genetics
• Systems Biology
• Autoimmune Diseases Research

Background:

• Type 1 diabetes (T1D) and multiple sclerosis (MS) are T cell-mediated autoimmune diseases.
• Identifying common genetic factors across autoimmune diseases is challenging.
• Convergent evidence suggests a shared genetic architecture for autoimmune conditions.

Purpose of the Study:

• To determine the common gene signature and pathways in T1D and MS.
• To utilize a systems biology approach for identifying shared molecular mechanisms.
• To explore potential common therapeutic targets for T1D and MS.

Main Methods:

• Analysis of gene expression profiles from peripheral blood mononuclear cells (PBMCs) and other relevant tissues (pancreatic-β cells in T1D, cerebrospinal fluid in MS).
• Integration of differential expressed genes with protein-protein interaction (PPI) data to construct Query-Query PPI (QQPPI) networks.
• Investigation of central genes, functional modules, and drug interactions within shared QQPPI networks.

Main Results:

• Several cytokines (e.g., IL-23A, IL-32) and specific genes (e.g., PSMA1, MYC, SRPK1) were found to be differentially expressed or highly central in both diseases.
• Shared biological processes include proteasome and spliceosome function, immune responses, apoptosis, and intercellular communication.
• Azathioprine, melatonin, resveratrol, and geldanamycin were identified as potential therapeutic drugs.

Conclusions:

• This research identified novel key genes and pathways common to both T1D and MS.
• The findings facilitate the identification of potential shared therapeutic targets for T1D and MS.
• This study contributes to understanding the underlying molecular connections between these autoimmune diseases.